Is Trevi Therapeutics, Inc. (TRVI) a Buy, Sell, or Hold?
Trevi Therapeutics, Inc.
NASDAQ:TRVI
$18.145 USD
$0.23 (1.31%)
- Volume
- 1.91M
- Average Volume
- 2.02M
- Market Capitalization
- $2.58B
- P/E Ratio
- -56.32
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $20.15
- Year Low
- $6.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.75
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-27.4% DOWNSIDE
$25.00 Price Target
UPSIDE/DOWNSIDE HIGH
-39.5% DOWNSIDE
$30.00 Price Target High
UPSIDE/DOWNSIDE LOW
-9.3% DOWNSIDE
$20.00 Price Target Low
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Annabel Samimy | $30 | $14.05 | 2026-05-08 07:34 AM | 113.5% |
| Leerink Partners | Roanna Ruiz | $16 | $11.31 | 2025-11-19 05:23 AM | 41.5% |
| Morgan Stanley | Judah Frommer | $19 | $11.6799 | 2025-11-14 08:19 AM | 62.7% |
| Oppenheimer | Leland Gershall | $24 | $11.8 | 2025-11-14 06:51 AM | 103.4% |
| H.C. Wainwright | Oren Livnat | $6 | $3.35 | 2024-10-22 02:59 AM | 79.1% |
| B.Riley Financial | Mayank Mamtani | $6 | $3.02 | 2024-10-04 08:48 AM | 98.7% |
| Oppenheimer | Leland Gershall | $12 | $3.95 | 2022-07-09 11:59 AM | 203.8% |